β-Arrestin 2 Regulates Inflammatory Responses against Mycobacterium tuberculosis Infection through ERK1/2 Signaling
Author(s) -
Qian Wen,
Yanfen Li,
Zhenyu Han,
Honglin Liu,
Shimeng Zhang,
Yaoxin Chen,
Jianchun He,
Xialin Du,
Yuling Fu,
Lijie Zhang,
Zelin Zhang,
Yulan Huang,
Xinying Zhou,
Chaoying Zhou,
Shengfeng Hu,
Li Ma
Publication year - 2021
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.2001346
Subject(s) - arrestin , mycobacterium tuberculosis , tlr2 , downregulation and upregulation , signal transduction , proinflammatory cytokine , biology , tuberculosis , gene silencing , microbiology and biotechnology , innate immune system , immune system , immunity , receptor , immunology , inflammation , g protein coupled receptor , medicine , genetics , pathology , gene
Mycobacterium tuberculosis, he pathogen that causes tuberculosis, exhibits complex host-pathogen interactions. Pattern recognition receptors and their downstream signaling pathways play crucial roles in determining the outcome of infection. In particular, the scaffold protein β-arrestin 2 mediates downstream signaling of G protein-coupled receptors. However, the role of β-arrestin 2 in conferring immunity agains M. tuberculosis has not yet been explored. We found that β-arrestin 2 was upregulated in the lesioned regions of lung tissues in patients with tuberculosis. M. tuberculosis infection upregulated β-arrestin 2 expression in human macrophages, and silencing of β-arrestin 2 significantly enhanced bactericidal activity by enhancing the expression of proinflammatory cytokines such as TNF-α. β-Arrestin 2 was shown to inhibit the activation of the TLR2/ERK1/2 pathway and its transcriptional regulation activity upon M. tuberculosis infection. Furthermore, β-arrestin 2 transcriptionally regulates TNF-α by binding to CREB1. These observations revealed that the upregulation of β-arrestin 2 is critical for M. tuberculosis o escape immune surveillance through an unknown mechanism. Our research offers a novel interference modality to enhance the immune response against tuberculosis by targeting β-arrestin 2 to modulate the TLR2-β-arrestin 2-ERK1/2-CREB1-TNF-α regulatory axis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom